{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:31:30Z","timestamp":1786984290751,"version":"build-2736575974"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Hypertension"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.amjhyper.2004.11.032","type":"journal-article","created":{"date-parts":[[2005,5,7]],"date-time":"2005-05-07T21:22:21Z","timestamp":1115500941000},"page":"720-730","source":"Crossref","is-referenced-by-count":108,"title":["Mechanisms for the Clinical Benefits of Angiotensin II Receptor Blockers"],"prefix":"10.1093","volume":"18","author":[{"given":"R","family":"SCHMIEDER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajh\/article-pdf\/18\/5\/720\/604873\/18_5_720.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T10:28:20Z","timestamp":1503397700000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article-lookup\/doi\/10.1016\/j.amjhyper.2004.11.032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0895706104011872"],"URL":"https:\/\/doi.org\/10.1016\/j.amjhyper.2004.11.032","relation":{},"ISSN":["0895-7061"],"issn-type":[{"value":"0895-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}